Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Allylestrenol

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,857Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Organon To Present At Piper Sandler Healthcare Conference
    Organon To Present At Piper Sandler Healthcare Conference

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125341955/en/Organon-To-Present-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    FDA Approves POHERDY® as First PERJETA Biosimilar
    FDA Approves POHERDY® as First PERJETA Biosimilar

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251117955804/en/Henlius-and-Organon-Announce-US-FDA-Approval-of-POHERDY-pertuzumab-dpzb-the-First-PERJETA-pertuzumab-Biosimilar-in-the-US

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Poherdy, First Biosimilar To Roche's Perjeta, Scores FDA Nod
    Poherdy, First Biosimilar To Roche's Perjeta, Scores FDA Nod

    14 Nov 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/organon-and-henlius-poherdy-first-biosimilar-roches-perjeta-approved-fda

    FIERCE PHARMA
    14 Nov 2025
    Share Share
    Organon Releases Q3 2025 Results
    Organon Releases Q3 2025 Results

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110058374/en/Organon-Reports-Results-for-the-Third-Quarter-Ended-September-30-2025

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    Vtama Cream Show Early & Consistent Response In Atopic Dermatitis
    Vtama Cream Show Early & Consistent Response In Atopic Dermatitis

    08 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251108738421/en/New-Data-Show-Early-and-Consistent-Response-to-VTAMA-tapinarof-Cream-1-in-Children-Aged-2-with-Atopic-Dermatitis-Including-Those-With-Associated-Comorbidities

    BUSINESSWIRE
    08 Nov 2025
    Share Share
    Organon To Sell JADA System To Laborie For Up To $465M
    Organon To Sell JADA System To Laborie For Up To $465M

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107954738/en/Organon-Announces-Agreement-to-Divest-its-JADA-System-for-Up-to-%24465-Million-to-Laborie

    BUSINESSWIRE
    07 Nov 2025
    Share Share